Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Free Dating
Ñompany Maksim-LLC. Ýëåêòðîïðèâîäû. Made and sell.
Popular Articles

NEJM Perspective Provides Overview Of Recent Health Reform Action
"Building Momentum as Democrats Forge Health Care Reform," New England Journal of Medicine: In a perspective piece, John Iglehart, a national correspondent for NEJM, reviews recent action on health reform. He discusses industry and provider groups" pledge to reduce spending by $2 trillion over the next 10 years, noting that the groups" pledge was a "recognition that the pace of reform is quickening and they wanted to be a full participant in negotiations." He also addresses congressional action, including discussions of a public insurance option and how lawmakers are attempting to address the cost of reform (Iglehart, NEJM, 5/14).
new payday loan lenders
Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease PROTOPIC Ointment Can Help Prevent Eczema Flares
Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.* It is now also approved for twice-weekly application to previously affected skin to prevent these exacerbations and prolong flare-free periods in PROTOPIC-responsive patients.ò€  Clinical studies have shown that this new approach brings significant benefits with over 40% of patients with moderate to severe eczema remaining flare-free for at least a year.1 Flares are known to place an enormous burden on patients. The International Study of Life with Atopic Eczema (ISOLATE) found that about 55% of these patients worried about the onset of their next exacerbation and that they spent on average over a third of the year (136 days) with their eczema in flare.2
News of the day
Infiltrating Blood-Derived Macrophages Are Vital Cells Playing An Anti-inflammatory Role In Recovery From Spinal Cord Injury In Mice
Although macrophages are known as essential players in wound healing,
Mental Health

Fish Protein Link To Controlling High Blood Pressure, New Study

Medical scientists at the University of Leicester are investigating how a species of fish from the Pacific Ocean could help provide answers to tackling chronic conditions such as hereditary high blood pressure and kidney disease. They are examining whether the Goby fish can help researchers locate genes linked to high blood pressure. This is because a protein called Urotensin II, first identified in the fish, is important for regulating blood pressure in all vertebrates- from fish to humans. The study is being carried out in the University"s Department of Cardiovascular Sciences. Researcher Dr Radoslaw Debiec said: "The protein found in the fish has remained almost unaltered during evolution". "This indicates that the protein might be of critical importance in regulation of blood pressure and understanding the genetic background of high blood pressure. "Uncovering the genetic causes of high blood pressure may help in its better prediction and early prevention of its complications. My research at the University of Leicester has shown how variation in the gene encoding the protein may influence risk of hypertension." Dr Debiec will be presenting his research at the Festival of Postgraduate Research which is taking place on Thursday 25th June in the Belvoir Suite, Charles Wilson Building at the University of Leicester between 11.30am and 1pm. He added: "Drugs affecting the protein might be a novel alternative to the available therapies in particular in those patients who have chronic kidney disease coexisting with high blood pressure. "Analysis of large cohort of families has provided us with evidence that genetic information encrypted in the protein travels together with the risk of high blood pressure across generations. Furthermore, the same genetic variant responsible for elevated blood pressure is responsible for the development of chronic kidney disease in this group of patients. "The present findings may have an impact on the development of new blood pressure-lowering medications." Dr Debiec"s study was supervised Dr. M. Tomaszewski (Department of Cardiovascular Sciences, Cardiology Group,) and Professor D.G. Lambert (Department of Cardiovascular Sciences; Pharmacology and Therapeutics Group). Leicester University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009